Neuren Pharmaceuticals reported AUD363.9M in Equity Capital and Reserves for its fiscal semester ending in December of 2024.


Equity Capital And Reserves Change Date
Alaunos Therapeutics USD 2.06M 661K Dec/2024
Avita Medical AUD 4.5M 19.42M Dec/2024
Clinuvel Pharmaceuticals AUD 203.01M 24.36M Jun/2024
Dianthus Therapeutics USD 303.08M 49.4M Jun/2025
Genetic Signatures AUD 54.59M 6.51M Dec/2024
Ionis Pharmaceuticals USD 631.72M 156M Jun/2025
Medical Developments International AUD 55.33M 9.6M Dec/2024
Neuren Pharmaceuticals AUD 363.9M 144.75M Dec/2024
Organon & Co USD 733M 191M Jun/2025
Paradigm Biopharmaceuticals AUD 34.06M 10.25M Dec/2024
PYC Therapeutics AUD 55.44M 25.62M Dec/2024
Starpharma Holdings AUD 23.17M 4.94M Dec/2024
Tectonic Therapeutic USD 283.77M 142.99M Jun/2025
Telix Pharmaceuticals AUD 568.21M 164.24M Dec/2024
Viatris USD 15.57B 79.9M Jun/2025
Xeris Pharmaceuticals USD -19300000 10.32M Jun/2025